South Korea Immunoassay Market

South Korea Immunoassay Market Overview:

The South Korea immunoassay market size reached USD 621.30 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 943.38 Million by 2033, exhibiting a growth rate (CAGR) of 4.75% during 2025-2033. The increasing prevalence of chronic diseases and infectious conditions in South Korea is driving the demand for accurate diagnostic tools like immunoassays, particularly with the aging population. Additionally, the rapid growth of digital health and telemedicine services, which requires remote diagnostic solutions, is further contributing to the expansion of the South Korea immunoassay market share.

South Korea Immunoassay Market Trends:

Rising Incidence of Chronic Diseases and Infectious Conditions

The growing prevalence of chronic illnesses like cancer, diabetes, and heart diseases is considerably driving the need for dependable diagnostic tests in South Korea. Immunoassays are becoming an essential method for identifying biomarkers associated with these conditions, providing precise and effective results. With the country's aging population intensifying the pressure on the healthcare system, early diagnosis and treatment are becoming critical. As per the 2024 Statistics on the Aged, those who are 65 years old and older constitute 19.2% of the population, a percentage anticipated to rise beyond 20% by 2025 and attain 30% by 2036. This demographic shift is contributing to a higher incidence of age-related diseases, putting additional strain on healthcare resources and increasing the need for effective diagnostic solutions. Moreover, infectious diseases continue to be a constant public health issue, catalyzing the demand for accurate diagnostic instruments. Immunoassays play a crucial role in identifying pathogens and controlling disease outbreaks, guaranteeing prompt recognition of infectious agents. The dual burden of chronic illnesses and infectious diseases highlights the importance of dependable and accessible diagnostic tests, such as immunoassays, which are crucial in South Korea's healthcare system, especially for controlling disease transmission and enhancing patient results. This rising demand for immunoassays to address changing healthcare challenges is significantly contributing to the South Korea immunoassay market growth.

Increasing Investments in Digital Health and Telemedicine

The swift growth of digital health technologies and telemedicine services in South Korea is creating substantial demand for remote diagnostic instruments, such as immunoassays. As virtual consultations and remote patient monitoring gain more attention, telemedicine platforms are incorporating diagnostic tools like immunoassays to deliver quick, precise test results without the need for in-person appointments. This transition towards digital healthcare options is increasing access to prompt medical services, especially in rural and disadvantaged regions where healthcare resources might be scarce. The growing use of telemedicine in South Korea is evidenced by the nation's telemedicine market, which attained a worth of USD 1,744.4 million in 2024. With the rise of telemedicine, there is a significant need for incorporating diagnostic technologies that are readily accessible and usable from a distance. Immunoassays, which are being more frequently integrated into telemedicine platforms, allow healthcare providers to deliver more thorough care to patients remotely. This integration improves the overall effectiveness of healthcare services, enabling quicker diagnoses and better management of different health issues. As the telemedicine sector continues to grow, immunoassays are emerging as an essential part of South Korea’s healthcare system, enhancing patient results by delivering precise diagnostics instantly, including for individuals lacking immediate access to conventional medical facilities.

South Korea Immunoassay Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country and regional levels for 2025-2033. Our report has categorized the market based on technology, product, application, and end use.

Technology Insights:

• Radioimmunoassay
• Enzyme Immunoassay
• Rapid Test
• Others

The report has provided a detailed breakup and analysis of the market based on the technology. This includes radioimmunoassay, enzyme immunoassay, rapid test, and others.

Product Insights:

• Reagents and Kits
• Analyzers/Instruments
• Software and Services

A detailed breakup and analysis of the market based on the product have also been provided in the report. This includes reagents and kits, analyzers/instruments, and software and services.

Application Insights:

• Therapeutic Drug Monitoring
• Oncology
• Cardiology
• Endocrinology
• Infectious Disease Testing
• Autoimmune Diseases
• Others

The report has provided a detailed breakup and analysis of the market based on the application. This includes therapeutic drug monitoring, oncology, cardiology, endocrinology, infectious disease testing, autoimmune diseases, and others.

End Use Insights:

• Hospitals
• Blood Banks
• Clinical Laboratories
• Pharmaceutical and Biotech Companies
• Academic Research Centers
• Others

A detailed breakup and analysis of the market based on the end use have also been provided in the report. This includes hospitals, blood banks, clinical laboratories, pharmaceutical and biotech companies, academic research centers, and others.

Regional Insights:

• Seoul Capital Area
• Yeongnam (Southeastern Region)
• Honam (Southwestern Region)
• Hoseo (Central Region)
• Others

The report has also provided a comprehensive analysis of all the major regional markets, which include Seoul Capital Area, Yeongnam (Southeastern Region), Honam (Southwestern Region), Hoseo (Central Region), and others.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

South Korea Immunoassay Market News:

• In June 2025, Quanterix announced its HD-X Simoa Immunoassay Analyzer has received Class 1 Medical Device registration in South Korea, enabling expansion through partner HS Biosystems. The platform allows ultra-sensitive biomarker detection, supporting Alzheimer's diagnostics globally.

South Korea Immunoassay Market Report Coverage:

Key Questions Answered in This Report:

• How has the South Korea immunoassay market performed so far and how will it perform in the coming years?
• What is the breakup of the South Korea immunoassay market on the basis of product?
• What is the breakup of the South Korea immunoassay market on the basis of technology?
• What is the breakup of the South Korea immunoassay market on the basis of application?
• What is the breakup of the South Korea immunoassay market on the basis of end use?
• What is the breakup of the South Korea immunoassay market on the basis of region?
• What are the various stages in the value chain of the South Korea immunoassay market? 
• What are the key driving factors and challenges in the South Korea immunoassay market?
• What is the structure of the South Korea immunoassay market and who are the key players?
• What is the degree of competition in the South Korea immunoassay market? 

Key Benefits for Stakeholders:

• IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the South Korea immunoassay market from 2019-2033.
• The research report provides the latest information on the market drivers, challenges, and opportunities in the South Korea immunoassay market.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the South Korea immunoassay industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.